Kiyoshi Komuta

3.3k total citations
76 papers, 1.4k citations indexed

About

Kiyoshi Komuta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kiyoshi Komuta has authored 76 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Kiyoshi Komuta's work include Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (27 papers) and Lung Cancer Diagnosis and Treatment (19 papers). Kiyoshi Komuta is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (27 papers) and Lung Cancer Diagnosis and Treatment (19 papers). Kiyoshi Komuta collaborates with scholars based in Japan. Kiyoshi Komuta's co-authors include Seigo Minami, Hiroaki Nanba, Noriko Kodama, Suguru Yamamoto, Kaoru Kubota, Kiyoyuki Furuse, Masaaki Kawahara, Masanori Fukushima, Koichi Minato and Yuka Fujita and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Kiyoshi Komuta

70 papers receiving 1.3k citations

Peers

Kiyoshi Komuta
Chi‐Li Chung Taiwan
Jong‐Sun Rew South Korea
Jianan Huang China
Gideon Steinbach United States
Vijayvel Jayaprakash United States
Lei Luo China
Li Zhong China
Hsin‐Chih Yeh Taiwan
Toshio Mitomi Japan
Manuel Castro de Moura Spain
Chi‐Li Chung Taiwan
Kiyoshi Komuta
Citations per year, relative to Kiyoshi Komuta Kiyoshi Komuta (= 1×) peers Chi‐Li Chung

Countries citing papers authored by Kiyoshi Komuta

Since Specialization
Citations

This map shows the geographic impact of Kiyoshi Komuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Komuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Komuta more than expected).

Fields of papers citing papers by Kiyoshi Komuta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoshi Komuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Komuta. The network helps show where Kiyoshi Komuta may publish in the future.

Co-authorship network of co-authors of Kiyoshi Komuta

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Komuta. A scholar is included among the top collaborators of Kiyoshi Komuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Komuta. Kiyoshi Komuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atagi, Shinji, Takashi Daimon, Kyoichi Okishio, et al.. (2023). A randomized phase III study of docetaxel alone versus docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer: JMTO LC09‐01. Thoracic Cancer. 14(29). 2941–2949. 1 indexed citations
2.
Minami, Seigo, et al.. (2020). Osimertinib-induced cardiac failure with QT prolongation and torsade de pointes in a patient with advanced pulmonary adenocarcinoma. International Cancer Conference Journal. 10(1). 68–71. 22 indexed citations
3.
4.
5.
Nakatani, Yuki, et al.. (2018). Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer. Case Reports in Neurology. 10(3). 346–352. 62 indexed citations
6.
Koba, Taro, Seigo Minami, Kentaro Masuhiro, et al.. (2018). Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 82(1). 111–117. 2 indexed citations
7.
Minami, Seigo, et al.. (2018). Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy. Journal of Clinical Medicine Research. 10(8). 657–664. 15 indexed citations
8.
9.
10.
11.
Yoshioka, Hiroshige, Kiyoshi Komuta, Fumio Imamura, et al.. (2014). Efficacy and safety of erlotinib in elderly patients in the phase IV POLARSTAR surveillance study of Japanese patients with non-small-cell lung cancer. Lung Cancer. 86(2). 201–206. 29 indexed citations
12.
Kawahara, Masaaki, Shinji Atagi, Kiyoshi Komuta, et al.. (2013). Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer.. PubMed. 33(10). 4631–7. 6 indexed citations
13.
Minami, Seigo, Takashi Kijima, Ryo Takahashi, et al.. (2012). Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study. BMC Cancer. 12(1). 296–296. 10 indexed citations
14.
Kawahara, Masaaki, Akihito Kubo, Kiyoshi Komuta, et al.. (2011). A Phase I Study of Amrubicin and Fixed Dose of Irinotecan (CPT-11) in Relapsed Small Cell Lung Cancer: Japan Multinational Trial Organization LC0303. Journal of Thoracic Oncology. 7(12). 1845–1849. 2 indexed citations
15.
Kodama, Noriko, Kiyoshi Komuta, & Hiroaki Nanba. (2003). Effect of Maitake ( Grifola frondosa ) D-Fraction on the Activation of NK Cells in Cancer Patients. Journal of Medicinal Food. 6(4). 371–377. 106 indexed citations
16.
Minami, Seigo, et al.. (2002). A Case of Gingival Metastasis of Pulmonary Anaplastic Carcinoma.. Haigan. 42(6). 595–599. 6 indexed citations
17.
Komuta, Kiyoshi, et al.. (1991). A Case of Malignant Fibrous Histiocytoma Originated from Posterior Mediastinum.. Haigan. 31(7). 1077–1082. 1 indexed citations
18.
Kawase, Ichiro, Kiyoshi Komuta, Takuma Shirasaka, et al.. (1989). Synergy of Nocardia rubra Cell Wall Skeleton and Interleukin 2 in the in vivo Induction of Murine Lymphokine‐activated Killer Cell Activity. Japanese Journal of Cancer Research. 80(11). 1089–1097. 1 indexed citations
19.
Hara, Hideki, Ichiro Kawase, Kiyoshi Komuta, Tomiya Masuno, & Susumu Kishimoto. (1989). Enhanced tumor growth and metastatic spread of an mh 134 variant lacking a part of the mm antigen: A possible role of antibody‐dependent cellular cytotoxicity in control of tumor growth and metastases. International Journal of Cancer. 44(1). 137–142. 1 indexed citations
20.
Yokota, Soichiro, Takuma Shirasaka, H Nishikawa, et al.. (1988). Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction. Cancer Immunology Immunotherapy. 26(1). 11–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi‐Li Chung Breakdown of academic impact, for papers by Jong‐Sun Rew Breakdown of academic impact, for papers by Jianan Huang Breakdown of academic impact, for papers by Gideon Steinbach Breakdown of academic impact, for papers by Vijayvel Jayaprakash Breakdown of academic impact, for papers by Lei Luo Breakdown of academic impact, for papers by Li Zhong Breakdown of academic impact, for papers by Hsin‐Chih Yeh Breakdown of academic impact, for papers by Toshio Mitomi Breakdown of academic impact, for papers by Manuel Castro de Moura
Rankless by CCL
2026